PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

ChatGPT shows promise in answering patients' questions to urologists

AI tool gives 'acceptable' responses to nearly half of questions, reports Urology Practice

2024-08-22
(Press-News.org) August 22, 2024 — The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer. 

The artificial intelligence (AI) tool generated "acceptable" responses to nearly one-half of a sample of real-life patient questions, according to the new research by Michael Scott, MD, a urologist at Stanford University School of Medicine. "Generative AI technologies may play a valuable role in providing prompt, accurate responses to routine patient questions – potentially alleviating patients' concerns while freeing up clinic time and resources to address other complex tasks," Dr. Scott comments. 

Can ChatGPT accurately answer questions from urology patients? 

ChatGPT is an innovative large language model (LLM) that has sparked interest across a wide range of settings, including health and medicine. In some recent studies, ChatGPT has performed well in responding to various types of medical questions, although its performance in urology is less well-established.  

Modern electronic health record (EHR) systems enable patients to send medical questions directly to their doctors. "This shift has been associated with an increased time burden of EHR use for physicians with a large portion of this attributed to patient in-basket messages," the researchers write. One study estimates that each message in a physician's inbox adds more than two minutes spent on the EHR. 

Dr. Scott and colleagues collected 100 electronic patient messages requesting medical advice from a urologist at a men's health clinic. The messages were categorized by type of content and difficulty, then entered into ChatGPT. Five experienced urologists graded each AI-generated response in terms of accuracy, completeness, helpfulness, and intelligibility. Raters also indicated whether they would send each response to a patient. 

Findings support 'generative AI technology to improve clinical efficiency' 

The ChatGPT-generated responses were judged to be accurate, with an average score of 4.0 on a five-point scale; and intelligible, average score 4.7. Ratings of completeness and helpfulness were lower, but with little or no potential for harm. Scores were comparable for different types of question content (symptoms, postoperative concerns, etc). 

"Overall, 47% of responses were deemed acceptable to send to patients," the researchers write. Questions rated as "easy" had a higher rate of acceptable responses: 56%, compared to 34% for "difficult" questions. 

"These results show promise for the utilization of generative AI technology to help improve clinical efficiency," Dr. Scott and coauthors write. The findings "suggest the feasibility of integrating this new technology into clinical care to improve efficiency while maintaining quality of patient communication." 

The researchers note some potential drawbacks of ChatGPT-generated responses to patient questions: "ChatGPT's model is trained on information from the Internet in general, as opposed to validated medical sources," with a "risk of generating inaccurate or misleading responses." The authors also highlight the need for safeguards to ensure patient privacy.  

"While our study provides an interesting starting point, more research will be needed to validate the use of LLMs to respond to patient questions, in urology as well as other specialties," Dr. Scott comments. "This will be a potentially valuable healthcare application, particularly with continued advances in AI technology." 

Read Article: Assessing Artificial Intelligence–Generated Responses to Urology Patient In-Basket Messages 

Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health. 

### 

About Wolters Kluwer 

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services. 

Wolters Kluwer reported 2023 annual revenues of €5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.  

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Facebook, YouTube and Instagram. 

END


ELSE PRESS RELEASES FROM THIS DATE:

T cells manipulate the memory of innate immune cells

2024-08-22
Research from Radboud university medical center reveals that T cells from the adaptive immune system can manipulate the memory of innate immune cells. Previously, it was believed that the memory of innate immune cells operated independently. This surprising connection opens up new possibilities for the treatment of various diseases. A mouse model shows that no immunosuppressive drugs are needed after an organ transplantation if this  interaction between T cells and the innate immunity is temporarily blocked after the transplantation. The adaptive immune ...

Immune cells have a metabolic backup plan for accessing their anti-cancer playbook

2024-08-22
GRAND RAPIDS, Mich. (Aug. 22, 2024) — Immune cells use two different routes to produce acetyl-CoA, an essential metabolite required to fight infection and cancer, reports a study led by Van Andel Institute scientists. The findings, published in the Journal of Experimental Medicine, could help improve immunotherapies by revealing how diet can boost immune cell function. “Like any good system, immune cells have a plan A and a plan B,” said Russell Jones, Ph.D., the study’s corresponding author and chair of VAI’s Department of Metabolism and Nutritional ...

A 3D ion Magnet, the new experimental frontier for quantum information processing

2024-08-22
Many quantum devices, from quantum sensors to quantum computers, use ions or charged atoms trapped with electric and magnetic fields as a hardware platform to process information.  However, current trapped-ion systems face important challenges. Most experiments are limited to one-dimensional chains or two-dimensional planes of ions, which constrain the scalability and functionality of quantum devices. Scientists have long dreamed of stacking these ions into three-dimensional structures, but this has been very difficult ...

A potential pathway may guide new therapies for inflammatory bowel disease and other inflammatory diseases

A potential pathway may guide new therapies for inflammatory bowel disease and other inflammatory diseases
2024-08-22
Philadelphia, August 22, 2024 – There is a critical unmet need to help tighten and maintain a healthy intestinal barrier and treat a leaky gut. Researchers have now found that a unique strain of probiotic bacteria, Bifidobacterium bifidum BB1, enhances intestinal barrier function and protects against penetration of bacteria and various harmful agents in the intestine. The findings, detailed in an article in The American Journal of Pathology, published by Elsevier, can help advance the development of novel, targeted, naturally occurring probiotic therapy for patients with inflammatory bowel disease (IBD) and other inflammatory diseases, such as fatty liver disease or alcoholic liver ...

CU researchers awarded $1.35 million grant to develop decision support technology for long-term care facilities

2024-08-22
Researchers from the University of Colorado College of Nursing and CU School of Medicine on the Anschutz Medical Campus were awarded a $1.35 million grant from the Agency for Healthcare Research and Quality (AHRQ) to design and implement technologies that improve resident safety and employee wellbeing at long-term care facilities. “Long-term care facilities in the United States are in crisis, they’re facing low resources and high staff turnover,” CU Nursing Associate Professor and ...

Alzheimer’s drug may someday help save lives by inducing a state of “suspended animation”

2024-08-22
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University report that they were able to successfully put tadpoles of Xenopus laevis frogs into a hibernation-like torpor state using donepezil (DNP), a drug approved by the FDA to treat Alzheimer’s. The team had previously used another drug, SNC80, to achieve similar results in tadpoles and enhance the survival of whole mammalian hearts for transplants, but SNC80 is not approved for clinical use in humans because it can cause seizures. By contrast, DNP is already being used in the clinic, meaning it potentially could be rapidly repurposed ...

New NSF Center for Pandemic Insights

New NSF Center for Pandemic Insights
2024-08-22
Preventing the next pandemic begins before diseases emerge. This “pre-emergence” phase is the focus of a new center funded by the U.S. National Science Foundation and led by the University of California, Davis.  Supported with $18 million over seven years, the U.S. National Science Foundation Center for Pandemic Insights (NSF CPI) includes partnering institutions from across the United States. It aims to harness new technologies and develop sensing to detect, investigate, and ultimately prevent ...

FAMU-FSU College of Engineering research shows how insulin, zinc and pH can block harmful protein clumps linked to Type 2 diabetes

FAMU-FSU College of Engineering research shows how insulin, zinc and pH can block harmful protein clumps linked to Type 2 diabetes
2024-08-22
An estimated 462 million people around the world suffer from Type 2 diabetes, a chronic disease in which the body has problems using sugar as a fuel, leading to a buildup of sugar in the blood and chronic health issues. New research led by Ayyalusamy Ramamoorthy, a professor at the FAMU-FSU College of Engineering and the Florida State University-headquartered National High Magnetic Field Laboratory, shows how zinc, pH levels and insulin work together to inhibit the buildup of protein clumps that contribute to this disease. The work, which points toward promising avenues for innovative treatments, ...

Fecal, blood, and urinary biomarkers in inflammatory bowel diseases

Fecal, blood, and urinary biomarkers in inflammatory bowel diseases
2024-08-22
The global burden of inflammatory bowel diseases (IBD), primarily Crohn's disease (CD) and ulcerative colitis (UC), continues to rise. Recent data show incidence rates of up to 17.8 cases per 100,000 person-years for CD and even higher for UC, reaching 28.4 per 100,000 person-years. These diseases primarily affect older populations and vary geographically, with higher prevalence rates in highly developed countries. Currently, endoscopic assessment through ileo-colonoscopy is the gold standard for diagnosing and monitoring IBD. However, this approach is invasive and often has limited availability, leading to long ...

ARDD 2024 | What can we do before the "cliff" of aging arrives?

ARDD 2024 | What can we do before the cliff of aging arrives?
2024-08-22
When exactly does the aging process start? With the aging mechanisms unclear, no consensus has been reached about aging “cliffs”, where our body functions and biological processes just change dramatically, as if overnight. In 2019, a study published in the authoritative peer-reviewed journal Nature Medicine, based on plasma proteomics data, identified 34, 60, and 78 years old as key time points of aging. In August 2024, Nature Aging, a Nature portfolio journal focusing on aging mechanisms, published the latest findings incorporating comprehensive data including transcriptomics and metabolomics, pinpointing the aging cliffs to the 40s and 60s. In the biomedical field, multi-omics ...

LAST 30 PRESS RELEASES:

Training to improve memory

Are patients undergoing surgery for early-stage cancer at risk of persistent opioid use?

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

[Press-News.org] ChatGPT shows promise in answering patients' questions to urologists
AI tool gives 'acceptable' responses to nearly half of questions, reports Urology Practice